BONUS-ZERTIFIKAT - FRESENIUS Stock

Certificat

DE000LB2JGJ8

Market Closed - Deutsche Boerse AG 11:15:11 2024-05-17 am EDT
27.56 EUR -2.17% Intraday chart for BONUS-ZERTIFIKAT - FRESENIUS
Current month+0.07%
1 month+5.19%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 27.56 -2.17%
24-05-16 28.17 -0.56%
24-05-15 28.33 +0.32%
24-05-14 28.24 -0.28%
24-05-13 28.32 +0.07%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 11:15 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
Issuer LBBW
WKN LB2JGJ
ISINDE000LB2JGJ8
Date issued 2020-08-06
Strike 50
Maturity 2024-08-16 (91 Days)
Parity 1 : 1
Emission price 43.42
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 45.46
Lowest since issue 18.73

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.94 EUR
Average target price
36.41 EUR
Spread / Average Target
+30.30%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW